BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9258655)

  • 1. Variable FHIT transcripts in non-neoplastic tissues.
    Panagopoulos I; Thelin S; Mertens F; Mitelman F; Aman P
    Genes Chromosomes Cancer; 1997 Aug; 19(4):215-9. PubMed ID: 9258655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.
    Luceri C; Guglielmi F; De Filippo C; Caderni G; Mini E; Biggeri A; Napoli C; Tonelli F; Cianchi F; Dolara P
    Scand J Gastroenterol; 2000 Jun; 35(6):637-41. PubMed ID: 10912665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas.
    Ferrer M; López-Borges S; Lazo PA
    Mol Carcinog; 1999 May; 25(1):55-63. PubMed ID: 10331745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [FHIT gene is abnormal in tongue carcinoma cell line].
    Liu F; Wu J; Sun Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):472-5. PubMed ID: 14565016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHIT gene abnormalities in both benign and malignant thyroid tumours.
    Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
    Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
    Mao L; Fan YH; Lotan R; Hong WK
    Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
    Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
    Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines].
    Lee SH; Kim HS
    Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract.
    Chen YJ; Chen PH; Lee MD; Chang JG
    Int J Cancer; 1997 Sep; 72(6):955-8. PubMed ID: 9378557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHIT mutations in human primary gastric cancer.
    Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
    Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.
    Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS
    Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal expression of the FHIT gene in human primary gastrointestinal cancers].
    Duan XM; Zhang GY; Wu ES
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):331-3. PubMed ID: 12205991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of FHIT gene expression in normal and leukaemic cells.
    Yang HW; Piao HY; Taki T; Chen T; Hashizume K; Ohnishi H; Bessho F; Yanagisawa M; Matsuo Y; Hayashi Y
    Int J Cancer; 1999 Jun; 81(6):897-901. PubMed ID: 10362136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
    Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
    Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.